NCT06369428View on ClinicalTrials.gov

Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma Patients

CompletedOBSERVATIONAL
Enrollment

1,795

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

April 13, 2023

Study Completion Date

April 13, 2023

Conditions
Metastatic Melanoma
Trial Locations (1)

4056

Novartis, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY